Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Wellnex Life Ltd ( (AU:WNX) ) has provided an update.
Wellnex Life Limited has issued 3,071,336 fully paid ordinary shares to former corporate advisors as a full and final settlement of outstanding fees for past advisory and capital-raising services. The shares are priced at A$0.074 each, based on the prior ASX closing price, and are being issued under the company’s existing placement capacity, with the new stock ranking equally with existing shares.
Application has been made for the new shares to be admitted to trading on AIM, with dealings expected to begin around 2 April 2026, and no treasury shares being held. Following admission, Wellnex Life’s issued share capital will increase to 73,026,812 ordinary shares, a new reference figure for investors’ disclosure and transparency calculations under FCA rules and the company’s constitution.
The most recent analyst rating on (AU:WNX) stock is a Hold with a A$0.09 price target. To see the full list of analyst forecasts on Wellnex Life Ltd stock, see the AU:WNX Stock Forecast page.
More about Wellnex Life Ltd
Wellnex Life Limited is an Australia- and UK-listed company on the ASX and AIM markets. It operates in the health and wellness sector, focusing on consumer products and brands, with its shares traded under the ticker WNX.
Average Trading Volume: 75,140
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$5.18M
See more data about WNX stock on TipRanks’ Stock Analysis page.